Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the website listed below. If a full
report of the study results is available, it also can be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03169959” into
the search box called “Other Terms”. Then, click “Search”.
The full title of your study is: A Randomized, 3-period, 3-treatment, Single-dose,
Open-label, Single-center, Crossover Study to Assess the Fed-state Bioequivalence of a
Triple Fixed-combination Drug Product of 2.5 mg Saxagliptin/5 mg Dapagliflozin/1000 mg
Metformin XR and 5 mg Saxagliptin/10 mg Dapagliflozin/1000 mg Metformin XR Relative
to Individual Components (ONGLYZA® and XIGDUO® XR) Co-administered to Healthy
Subjects
The protocol number of your study is: D168AC00001
AstraZeneca AB sponsored this study and has its headquarters in Södertälje, Sweden.
The phone number for the AstraZeneca Information Center is 1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for participants.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 510 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
V2.0 07/2018 6